Linezolid Aurobindo Italia

Linezolid, the active ingredient in Linezolid Aurobindo Italia, is an oxazolidinone presented as a tablet for oral use. It treats infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA), and is indicated for skin and soft‑tissue infections and community‑acquired pneumonia.

GNH USA supplies Linezolid Aurobindo Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibiotic indicated for several Gram‑positive bacterial infections.

- Skin and soft tissue infections: eradicates susceptible pathogens, including MRSA, to promote healing. - Community‑acquired pneumonia: clears respiratory infection caused by linezolid‑sensitive organisms. - Infections caused by susceptible Gram‑positive bacteria: treats bacteremia, endocarditis and other serious infections where linezolid is active.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Metallic taste: altered taste perception. - Vomiting: occasional emesis. - Insomnia: difficulty sleeping.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Anemia: reduced red blood cell levels. - Peripheral neuropathy: nerve pain or tingling. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: rare metabolic disturbance. - Severe allergic reactions: rash, swelling, or anaphylaxis.

When prescribing linezolid, clinicians should consider several safety factors.

- Renal impairment: monitor renal function and adjust therapy if needed. - Hepatic impairment: assess liver enzymes and consider dose modification. - Concomitant serotonergic agents: avoid or monitor for serotonin syndrome. - Myelosuppression: perform regular blood‑count monitoring. - Pregnancy and lactation: use only when benefits outweigh potential risks. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - SSRIs/SNRIs: potential serotonin syndrome. - Rifampin: reduces linezolid plasma concentrations. - Warfarin: may increase INR and bleeding risk. - Anticoagulants: enhanced anticoagulant effect.

Moderate Interactions (Monitor Closely): - NSAIDs: increased bleeding tendency. - Phenytoin: may lower linezolid levels. - Oral contraceptives: possible reduction in efficacy. - Statins: monitor for myopathy. - Proton‑pump inhibitors: may affect absorption.